Members Area Login

Go to the login page

Want to be a Member?

Click here
Contact us
FAQ

IPEC Europe

Supporting the interests of pharmaceutical excipient developers, producers, distributors and users.

Meet the Board

 

Frithjof Holtz

IPEC Europe Chair

 

Mr. Frithjof Holtz is a biologist and has been working for more than 26 years with Merck KGaA, Darmstadt, Germany, having a long year experience in quality assurance and regulatory affairs. Besides experience in chemical manufacturing (excipients/APIs) he has also working experience in quality assurance for drug products (sterile/non-sterile).

 

Furthermore he is now working for more than 12 years in Regulatory Affairs (CMC) for pharmaceutical starting materials. Currently he is responsible for the coordination of the advocacy & surveillance activities of Merck Life Science.

 

 

 

 

 

   

Frank Milek

IPEC Europe Vice-Chair

 
                  

 

          

Dr. Frank Milek is an industrial pharmacist and has been working in pharmaceutical excipients industry for more than 15 years, specialised in the field of supply chain and distribution. He is registered QP according to EU regulation and responsible at Aug. Hedinger GmbH & Co. KG for Quality, Regulatory Affairs and GMP.

 

Frank is currently the Chair of the GTDP Committee in FECC (European Association of Chemical Distributors) and an active member of the EXCiPACT project.

 

 

   

Dominik Odenbach       

IPEC Europe Treasurer

 

Dr. Dominik Odenbach is a biologist working since 10 years in the pharmaceutical industry in various positions in production and mainly regulatory affairs for companies like Abbott and BASF.

 

In his current role as Director for Global Regulatory & External Affairs, he is responsible for all regulatory affairs activities in the segments Pharma Solutions & Human Nutrition.

 
     

Karine Roth

IPEC Europe Secretary

 

Karine Roth is a Pharmacist and has more than 20  years of experience within Pharmaceutical Industry.

 

She is currently working with Novartis as Global  Head Biologics QA; her role includes QA/QC oversight of  development and manufacturing activities for Biologics products. Previously she used to lead organization looking at  QA Oversight of suppliers and parenteral contract manufacturers.

 

Prior Novartis, she has worked for Eli Lilly in several management position in Regulatory, Supplier Quality Assurance and Operational Excellence.

 
     

Marie Lesenne

   
 

Marie Lesenne is an engineer who has been working for Roquette since mid-2001 in several position such as Site QA Manager, responsible of several products release or Pharmaceuticals and Cosmetics Quality Manager, responsible of product complaint investigation, documentation review and on-site customer audits.


She is now the Head of Global Customer QA in charge of a team of approx. 20 people taking care of quality commitments and documentation (specifications, questionnaires, quality statements and agreements...) and guaranteeing the quality robustness and performance of Roquette at a global level to ensure customers satisfaction.

 

 

 

   

Amina Faham

   

 

Amina is a Biochemist and earned a Ph.D. degree in Pharmaceutical sciences from school of pharmacy, La Timone France. Amina has over 10 years of pharma industry experience in oral solid dosage forms with emphasis on modified drug release technologies, process development and optimization, production trouble shooting, and project management with companies including Wyeth/Pfizer Pharmaceuticals and Colorcon.

 

Amina has a strong background and experience of drug product development, CGMPs and the concepts of the modern quality systems. She is also Knowledgeable about operating discipline management systems. She joined DOW in Horgen Switzerland in 2011, as a senior pharmaceutical development application manager supporting the business in EMEA region.

 
     

Liz Meehan

   

Liz Meehan is a material scientist with a PhD from City University, London and more than 30 years experience in material characterisation.

 

She has worked in the pharmaceutical industry for 10 years, in the Pharmaceutical Development department of AstraZeneca, specialising in the field of excipient characterisation, relating excipient properties to functionality in dosage form design. More generally her activities include excipient risk assessment/mitigation for the development of robust pharmaceutical formulations.

 

 

   

Mahmud Yunis

 

Dr. Mahmud Yunis has been working for 10 years at BIOGRUND in several positions.

 

In his current function as Technical Director, he is responsible for preparing and implementing global strategic regulatory plan for BIOGRUND products and the strategic development of the Quality, Production and R&D department. He has a PhD degree in Analytical Chemistry from University of Muenster, Germany.  Before joining BIOGRUND he worked for a consulting company on the area of GxP procedures and processes for five years.

 

Newsletter Subscription

Sign up for our subscriber newsletter!